Regional quantification of cardiac metabolism with hyperpolarized [1-13C]-pyruvate CMR evaluated in an oral glucose challenge

被引:5
|
作者
Larson, Peder E. Z. [1 ,2 ,3 ]
Tang, Shuyu [1 ,2 ,3 ,4 ]
Liu, Xiaoxi [1 ]
Sinha, Avantika [1 ]
Dwork, Nicholas [1 ,5 ]
Sivalokanathan, Sanjay [6 ]
Liu, Jing [1 ]
Bok, Robert [1 ]
Ordovas, Karen G. [1 ,8 ]
Slater, James [1 ]
Gordon, Jeremy W. [1 ]
Abraham, M. Roselle [7 ]
机构
[1] Univ CA San Francisco, Dept Radiol & Biomed Imaging, 1700 4th St,Byers Hall Room 102C, San Francisco, CA 94143 USA
[2] Univ Calif Berkeley, UC Berkeley UCSF Grad Program Bioengn, Berkeley, CA 94143 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Vista Ai, Palo Alto, CA USA
[5] Univ Colorado, Sch Med, Dept Bioinformat & Radiol, Denver, CO USA
[6] Univ Penn, Dept Internal Med, Div Med, Philadelphia, PA USA
[7] Univ Calif San Francisco, Dept Med, Cardiol Div, San Francisco, CA USA
[8] Univ Washington, Dept Radiol, Seattle, WA USA
关键词
D O I
10.1186/s12968-023-00972-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
<bold>Background: </bold>The heart has metabolic flexibility, which is influenced by fed/fasting states, and pathologies such as myocardial ischemia and hypertrophic cardiomyopathy (HCM). Hyperpolarized (HP) C-13-pyruvate MRI is a promising new tool for non-invasive quantification of myocardial glycolytic and Krebs cycle flux. However, human studies of HP C-13-MRI have yet to demonstrate regional quantification of metabolism, which is important in regional ischemia and HCM patients with asymmetric septal/apical hypertrophy.<bold>Methods: </bold>We developed and applied methods for whole-heart imaging of C-13-pyruvate, C-13-lactate and C-13-bicarbonate, following intravenous administration of [1-C-13]-pyruvate. The image acquisition used an autonomous scanning method including bolus tracking, real-time magnetic field calibrations and metabolite-specific imaging. For quantification of metabolism, we evaluated C-13 metabolite images, ratio metrics, and pharmacokinetic modeling to provide measurements of myocardial lactate dehydrogenase (LDH) and pyruvate dehydrogenase (PDH) mediated metabolic conversion in 5 healthy volunteers (fasting & 30 min following oral glucose load).<bold>Results: </bold>We demonstrate whole heart coverage for dynamic measurement of pyruvate-to-lactate conversion via LDH and pyruvate-to-bicarbonate conversion via PDH at a resolution of 6 x 6 x 21 mm(3) (C-13-pyruvate) and 12 x 12 x 21 mm(3) (C-13-lactate, C-13-bicarbonate). C-13-pyruvate and C-13-lactate were detected simultaneously in the RV blood pool, immediately after intravenous injection, reflecting LDH activity in blood. In healthy volunteers, myocardial C-13-pyruvate-SNR, C-13-lactate-SNR, C-13-bicarbonate-SNR, C-13-lactate/pyruvate ratio, C-13-pyruvate-to-lactate conversion rate, k(PL), and C-13-pyruvate-to-bicarbonate conversion rate, k(PB), all had statistically significant increases following oral glucose challenge. k(PB), reflecting PDH activity and pyruvate entering the Krebs Cycle, had the highest correlation with blood glucose levels and was statistically significant.<bold>Conclusions: </bold>We demonstrate first-in-human regional quantifications of cardiac metabolism by HP C-13-pyruvate MRI that aims to reflect LDH and PDH activity.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Pharmacodynamics and pharmacokinetics of hyperpolarized [1-13C]-pyruvate in a translational oncologic model
    Perkons, Nicholas R.
    Johnson, Omar
    Pilla, Gabrielle
    Gade, Terence P. F.
    NMR IN BIOMEDICINE, 2021, 34 (06)
  • [42] Segmental analysis of cardiac metabolism by hyperpolarized [1-13C] pyruvate: an in-vivo 3D MRI study in pigs
    Vincenzo Positano
    Maria Filomena Santarelli
    Francesca Frijia
    Giovanni Aquaro
    Luca Menichetti
    Vincenzo Lionetti
    Giacomo Bianchi
    Alessandra Flori
    Jan Henrik Ardenkjaer-Larsen
    Florian Wiesinger
    Rolf F Schulte
    Giulio Giovannetti
    Fabio A Recchia
    Luigi Landini
    Massimo Lombardi
    Journal of Cardiovascular Magnetic Resonance, 14 (Suppl 1)
  • [43] Apparent rate constant mapping using hyperpolarized [1-13C]pyruvate
    Khegai, O.
    Schulte, R. F.
    Janich, M. A.
    Menzel, M. I.
    Farrell, E.
    Otto, A. M.
    Ardenkjaer-Larsen, J. H.
    Glaser, S. J.
    Haase, A.
    Schwaiger, M.
    Wiesinger, F.
    NMR IN BIOMEDICINE, 2014, 27 (10) : 1256 - 1265
  • [44] Radial Spectroscopic MRI of Hyperpolarized [1-13C] Pyruvate at 7 Tesla
    Ramirez, Marc S.
    Lee, Jaehyuk
    Walker, Christopher M.
    Sandulache, Vlad C.
    Hennel, Franciszek
    Lai, Stephen Y.
    Bankson, James A.
    MAGNETIC RESONANCE IN MEDICINE, 2014, 72 (04) : 986 - 995
  • [45] Metabolic imaging with hyperpolarized [1-13C]-pyruvate and DCE-MRI
    Bankson, James A.
    Walker, Christopher M.
    Chen, Yunyun
    Lai, Stephen Y.
    Hazle, John D.
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [46] Parahydrogen Hyperpolarized [1-13C] Pyruvate for the Investigation of Altered Metabolic Pathways
    Reineri, F.
    Cavallari, E.
    Carrera, C.
    Aime, S.
    INVESTIGATIVE RADIOLOGY, 2019, 54 (12) : 802 - 803
  • [47] Optimization of Spatial and Spectral Encoding for Hyperpolarized [1-13C]Pyruvate MRI
    Michel, K.
    Walker, C.
    Merritt, M.
    Bankson, J.
    MEDICAL PHYSICS, 2019, 46 (06) : E129 - E129
  • [48] Evaluating Lung Inflammation Using Hyperpolarized 1-13c Pyruvate Imaging
    Siddiqui, S.
    Shaghaghi, H.
    Kadlecek, S.
    Profka, H.
    Kuzma, N.
    Ishii, M.
    Rizi, R. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [49] Potential Clinical Roles for Metabolic Imaging with Hyperpolarized [1-13C]Pyruvate
    Serrao, Eva M.
    Brindle, Kevin M.
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [50] Imaging Regional Metabolic Changes in the Ischemic Rat Heart In Vivo Using Hyperpolarized [1-13C] Pyruvate
    Lauritzen, Mette Hauge
    Magnusson, Peter
    Laustsen, Christoffer
    Butt, Sadia Asghar
    Ardenkjaer-Larsen, Jan Henrik
    Sogaard, Lise Vejby
    Paulson, Olaf B.
    Akeson, Per
    TOMOGRAPHY, 2017, 3 (03) : 123 - 130